These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5412087)

  • 1. 1,4-bis(2-indol-3-ylethyl)piperidines.
    Archibald JL; Baum T; Childress SJ
    J Med Chem; 1970 Jan; 13(1):138-40. PubMed ID: 5412087
    [No Abstract]   [Full Text] [Related]  

  • 2. Piperidylalkylindoles. 1. Hypotensive activity of 3-[2-(phenoxypiperidyl)ethyl]indoles.
    Helsley GC; Strupczewski J; Woodward DL
    J Med Chem; 1978 Mar; 21(3):309-12. PubMed ID: 628008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzamidopiperidines. 2. Heterocyclic compounds related to indoramin.
    Archibald JL; Benke GA
    J Med Chem; 1974 Jul; 17(7):736-9. PubMed ID: 4151968
    [No Abstract]   [Full Text] [Related]  

  • 4. Benzamidopiperidines. 3. Carbocyclic derivatives related to indoramin.
    Archibald JL; Fairbrother P; Jackson JL
    J Med Chem; 1974 Jul; 17(7):739-45. PubMed ID: 4151791
    [No Abstract]   [Full Text] [Related]  

  • 5. 1'4-Bis(2-indol-3ylethyl)piperazines.
    Archibald JL; Freed ME
    J Med Chem; 1974 Jul; 17(7):745-7. PubMed ID: 4836405
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of 3-(4-acylaminopiperazin-1-ylalkyl)indoles as potential antihypertensive agents.
    Glamkowski EJ; Reitano PA; Woodward DL
    J Med Chem; 1977 Nov; 20(11):1485-9. PubMed ID: 915910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution to the clinical trial of a new antihypertensive agent].
    Capuano G; Santoro C
    Rass Int Clin Ter; 1969 May; 49(10):615-20. PubMed ID: 5784808
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
    Chen A; Cauchon E; Chefson A; Dolman S; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Gallant M; Grimm E; Han Y; Houle R; Huang JQ; Hughes G; Jûteau H; Lacombe P; Lauzon S; Lévesque JF; Liu S; Macdonald D; Mackay B; McKay D; Percival MD; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3976-81. PubMed ID: 21641209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive ureidopiperidines.
    Archibald JL; Beardsley DR; Bisset GM; Fairbrother P; Jackson JL; Opalko A; Ward TJ
    J Med Chem; 1980 Aug; 23(8):857-61. PubMed ID: 7401114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and hypotensive activity of benzamidopiperidylethylindoles.
    Archibald JL; Alps BJ; Cavalla JF; Jackson JL
    J Med Chem; 1971 Nov; 14(11):1054-9. PubMed ID: 5115203
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of a compound preparation (DCR 515) in the treatment of arterl hypertension (double blind test)].
    Maximilian V; Gavrilă F; Zeană C; Bărbulescu I; Dimitriu CG
    Med Interna (Bucur); 1970 Mar; 22(3):297-305. PubMed ID: 5444367
    [No Abstract]   [Full Text] [Related]  

  • 12. Double blind controlled trial of indoramin in the treatment of essential hypertension.
    Dollery DT; George DG; Lewis PJ
    Br J Pharmacol; 1972 Nov; 46(3):542P-543P. PubMed ID: 4571183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of indole derivatives on enterochromaffin cells in experimental hypertension].
    Il'iuchenok TIu; Talapin VI; Shadurskiĭ KS
    Farmakol Toksikol; 1969; 32(3):304-6. PubMed ID: 5810946
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ambulatory therapy of hypertension with briserin mite].
    Schütz E
    Med Welt; 1970 May; 22():1040-3. PubMed ID: 5509755
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
    Kramer R; Rosendorff C; Bloom D
    S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
    J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accomplishing 2 goals at once. Nephropathy and cardiac risk].
    MMW Fortschr Med; 2000 Jul; 142(30):51. PubMed ID: 10955024
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
    Royds RB
    Br J Pharmacol; 1972 Feb; 44(2):379P-380P. PubMed ID: 4668635
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and evaluation of 3-substituted 1-[4-(2-indol-3-ylethyl)piperazinyl]ureas as potential antihypertensive agents.
    Glamkowski EJ; Reitano PA; Woodward DL
    J Pharm Sci; 1978 Dec; 67(12):1773-4. PubMed ID: 722502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minoxidil--an alternative to nephrectomy for refractory hypertension.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1973 Jul; 289(4):167-71. PubMed ID: 4268267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.